Markers of apoptosis in cardiovascular tissues: Focus on Annexin V

Cardiovascular Research

Volumn 45, Issue 3, 2000, Pages 549-559

  Van Heerde, Waander L ^a   Robert Offerman, Saskia ^a   Dumont, Ewald ^a   Hofstra, Leo ^a   Doevendans, Pieter A ^a   Smits, Jos F M ^a   Daemen, Mat J A P ^a   Reutelingsperger, Chris P M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Atherosclerosis; Cardiomyopathy; Heart failure; Ischemia

Indexed keywords

DNA FRAGMENT; LIPOCORTIN 5;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; CELL STRUCTURE; CLINICAL PROTOCOL; ELECTRON MICROSCOPY; HEART DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MICROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; TECHNIQUE;

ANIMALS; ANNEXIN A5; APOPTOSIS; BIOLOGICAL MARKERS; CALCIUM; CARDIOVASCULAR DISEASES; CASPASES; CELL MEMBRANE; CYTOPLASM; DNA FRAGMENTATION; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON; MITOCHONDRIA, HEART; MYOCARDIUM; PHOSPHATIDYLSERINES;

EID: 0033959019     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00396-X     Document Type: Review

References (114)

1. Watanabe M., Choudhry A., Berlan M., et al. Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. Development. 125:1998;3809-3820.
2. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 99:1999;348-353.
3. Kockx M.M., De Meyer G.R., Buyssens N., et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 83:1998;378-387.
4. Lutgens E., Daemen M.J.A.P., Kockxs M., et al. Atherosclerosis in APOE*3-Leiden transgenic mice. From proliferative to atheromatous stage. Circulation. 99:1999;276-283.
5. Shindo J., Ishibashi T., Yokoyama K., et al. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits. Circulation. 99:1999;2150-2156.
6. Fukumoto H., Naito Z., Asano G., Aramaki T. Immunohistochemical and morphometric evaluations of coronary atherosclerotic plaques associated with myocardial infarction and diabetes mellitus. J Atheroscler Thromb. 5:1998;29-35.
7. Hamet P., Moreau P., Dam T.V., et al. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. J Hypertens Suppl. 14:1996;S65-S70.
8. DeBlois D., Tea B.S., Than V.D., Tremblay J., Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 29:1997;340-349.
9. Akyurek L.M., Johnsson C., Lange D., et al. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis. J Clin Invest. 101:1998;2889-2899.
10. Hirsch G.M., Kearsey J., Burt T., Karnovsky M.J., Lee T. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis. Eur J Cardiothorac Surg. 14:1998;89-96.
11. Slomp J., Gittenberger-de Groot A.C., Glukhova M.A., et al. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol. 17:1997;1003-1009.
12. Lizard G., Monier S., Cordelet C., et al. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol. 19:1999;1190-1200.
13. Langille B.L. Arterial remodeling: relation to hemodynamics. Can J Physiol Pharmacol. 74:1996;834-841.
14. Cho A., Courtman D.W., Langille B.L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 76:1995;168-175.
15. Bauriedel G., Schluckebier S., Hutter R., et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 18:1998;1132-1139.
16. Frustaci A., Chimenti C., Setoguchi M., et al. Cell death in acromegalic cardiomyopathy. Circulation. 99:1999;1426-1434.
17. Valente M., Calabrese F., Thiene G., et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 152:1998;479-484.
18. Fontaliran F., Arkwright S., Vilde F., Fontaine G. Arrhythmogenic right ventricular dysplasia and cardiomyopathy. Clinical and anatomic-pathologic aspects, nosologic approach. Arch Anat Cytol Pathol. 46:1998;171-177.
19. Kageyama Y., Li X.K., Suzuki S., et al. Apoptosis is involved in acute cardiac allograft rejection in rats. Ann Thorac Surg. 65:1998;1604-1609.
20. Koglin J., Russell M.E. Alloimmune-mediated apoptosis: comparison in mouse models of acute and chronic cardiac rejection. Transplantation. 67:1999;904-909.
21. Vriens P.W., Blankenberg F.G., Stoot J.H., et al. The use of technetium Tc 99m Annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg. 116:1998;844-853.
22. Blankenberg F.G., Katsikis P.D., Tait J.F., et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 95:1998;6349-6354.
23. Takeda K., Yu Z.X., Nishikawa T., et al. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J Mol Cell Cardiol. 28:1996;209-215.
24. Poelmann R.E., Mikawa T., Gittenberger-De Groot A.C. Neural crest cells in outflow tract septation of the embryonic chicken heart: differentiation and apoptosis. Dev Dyn. 212:1998;373-384.
25. Saphier C.J., Yeh J. Altered apoptosis levels in hearts of human fetuses with Down syndrome. Am J Obstet Gynecol. 179:1998;962-965.
26. Elsässer A., Schlepper M., Klövekorn W.P., et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 96:1997;2920-2931.
27. Chen C., Ma L., Linfert D.R., et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol. 30:1997;1407-1412.
28. 1-adrenoceptors involves inhibition of apoptosis. J Thorac Cardiovasc Surg. 117:1999;980-986.
29. Narula J., Hajjar R.J., Dec G.W. Apoptosis in the failing heart. Cardiol Clin. 16:1998;691-710.
30. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 79:1999;215-262.
31. Freude B., Masters T.N., Kostin S., Robicsek F., Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol. 93:1998;85-89.
32. Zhang J., Andrade Z.A., Yu Z.X., et al. Apoptosis in a canine model of acute Chagasic myocarditis. J Mol Cell Cardiol. 31:1999;581-596.
33. Rossi M.A., Souza A.C. Is apoptosis a mechanism of cell death of cardiomyocytes in chronic Chagasic myocarditis? Int J Cardiol. 68:1999;325-331.
34. James T.N., St. Martin E., Willis P.W. III, Lohr T.O. Apoptosis as a possible cause of gradual development of complete heart block and fetal arrhythmias associated with absence of the AV node, sinus node, and internodal pathways. Circulation. 93:1996;1424-1438.
35. Seki Y., Kai H., Kai M., et al. Myocardial DNA strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy. Clin Cardiol. 21:1998;591-596.
36. Saraste A., Pulkki K., Kallajoki M., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest. 29:1999;380-386.
37. Feuerstein G., Yue T.L., Ma X., Ruffolo R.R. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis. 48:(Suppl 1):1998;17-24.
38. Diez J., Panizo A., Hernandez M., et al. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension. 30:1997;1029-1034.
39. Ohno M., Takemura G., Ohno A., et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation. 98:1998;1422-1430.
40. Anversa P., Cheng W., Liu Y., et al. Apoptosis and myocardial infarction. Basic Res Cardiol. 93:(Suppl 3):1998;8-12.
41. Dong C., Wilson J.E., Winters G.L., McManus B.M. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest. 74:1996;921-931.
42. Colston J.T., Chandrasekar B., Freeman G.L. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res. 38:1998;158-168.
43. Gebhard J.R., Perry C.M., Harkins S., et al. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol. 153:1998;417-428.
44. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
45. Kroemer G., Petit P.X., Zamzami N., Vayssiere J.L., Mignotte B. The biochemistry of apoptosis. FASEB J. 9:1995;1277-1287.
46. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
47. Evan G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
48. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
49. Susin S.A., Zamzami N., Castedo M., et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med. 186:1997;25-37.
50. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
51. Susin S.A., Lorenzo H.K., Zamzami N., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
52. Kluck R.M., Bossy Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
53. Mancini M., Nicholson D.W., Roy S., et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol. 140:1998;1485-1495.
54. Susin S.A., Lorenzo H.K., Zamzami N., et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med. 189:1999;381-394.
55. Slee E.A., Harte M.T., Kluck R.M., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 144:1999;281-292.
56. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basis biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
57. Cotter T.G., Martin S.J. Techniques in apoptosis. A user's guide. 1996;Portland Press, London.
58. Majno G., Joris I. Apoptosis, oncosis and necrosis. Am J Pathol. 146:1995;3-15.
59. Gorman A., McCarthy J., Finucane D., Reville W., Cotter T. Morphological assessment of apoptosis. Cotter T.G., Martin S.J. Techniques in apoptosis. A user's guide. 1996;1-20 Portland Press, London.
60. Darzynkiewicz Z., Bruno S., DelBino G., et al. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
61. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
62. Gurtu V., Kain S.R., Zhang G. Fluorometric and colorometric detection of caspase activity associated with apoptosis. Anal Biochem. 251:1997;98-102.
63. Leers M.P.G., Kolgen W., Bjorkland V., et al. Immunocytochemical detection and mapping of a cytokeratin 18 neoepitope exposed during early apoptosis. J Pathol. 187:1999;567-572.
64. Yang F., Sun X., Beech W., et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol. 152:1998;379-389.
65. Sallmann F.R., Bourassa S., Saint-Cyr J., Poirier G.G. Characterization of antibodies specific for the caspase cleavage site on poly(ADP-ribose) polymerase: specific detection of apoptotic fragments and mapping of the necrotic fragments of poly(ADP-ribose) polymerase. Biochem Cell Biol. 75:1997;451-456.
66. McConkey D.J. Calcium flux measurement in cell death. Cotter T.G., Martin S.J. Techniques in apoptosis. A user's guide. 1996;133-148 Portland Press, London.
67. Berridge M., Lipp P., Bootman M. Calcium signalling. Curr Biol. 9:1999;R157-159.
68. Whyte M.K., Hardwick S.J., Meagher L.C., Savill J.S., Haslett C. Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro. J Clin Invest. 92:1993;446-453.
69. Metivier D., Dallaporta B., Zamzami N., et al. Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol Lett. 61:1998;157-163.
70. Bossy-Wetzel E., Newmeyer D.D., Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
71. Krajewski S., Krajewska M., Ellerby L.M., et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA. 96:1999;5752-5757.
72. Itoh G., Tamura J., Suzuki M., et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol. 146:1995;1325-1331.
73. Staley K., Blaschke A.J., Chun J. Apoptotic DNA fragmentation is detected by a semiquantitative ligation mediated PCR of blunt DNA ends. Cell Death Diff. 4:1997;66-75.
74. Darzynkiewicz Z., Li X. Measurements of cell death by flow cytometry. Cotter T.G., Martin S.J. Techniques in apoptosis. A user's guide. 1996;71-106 Portland Press, London.
75. Meyaard L., Otto S.A., Jonker R.R., et al. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
76. Gorczyca W., Bruno S., Darzynkiewicz R.J., Gong J., Darzynkiewicz Z. DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol. 1:1992;639-648.
77. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
78. Kockx M.M., Muhring J., Bortier H., DeMeyer G.R.Y., Jacob W. Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques. Am J Pathol. 148:1996;1771-1777.
79. Kockx M.M., Muhring J., Knaapen M.W.M., de Meyer G.R. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
80. Fadok V.A., Voelker D.R., Campbell P.A., et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 148:1992;2207-2216.
81. Andree H.A., Reutelingsperger C.P.M., Hauptmann R., et al. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem. 265:1990;4923-4928.
82. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C.P.M. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 184:1995;39-52.
83. Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
84. Homburg C.H.E., De Haas M., Von Dem Borne A.E.G.K., et al. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85:1995;532-540.
85. Martin S.J., Reutelingsperger C.P.M., McGahon A.J., et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 182:1995;1545-1557.
86. Seigneuret M., Devaux P.F. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape change. Proc Natl Acad Sci USA. 81:1984;3751-3755.
87. Diaz C., Schroit A.J. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol. 151:1996;1-9.
88. Zwaal R.F.A., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 89:1997;1121-1132.
89. Bevers E.M., Comfurius P., van Rijn J.L.M.L., Hemker H.C., Zwaal R.F.A. Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem. 122:1982;429-436.
90. Bevers E.M., Comfurius P., Zwaal R.F.A. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta. 736:1983;57-66.
91. Williamson P., Bevers E.M., Smeets E.F., et al. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry. 34:1995;10448-10455.
92. Verhoven B., Schlegel R.A., Williamson P. Mechanism of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J Exp Med. 182:1995;1597-1601.
93. Schroit A.J., Madsen J.W., Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem. 260:1985;5131-5138.
94. Reutelingsperger C.P.M., Hornstra G., Hemker H.C. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem. 151:1985;625-629.
95. Tait J.F., Gibson D., Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem. 264:1989;7944-7949.
96. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein Annexin V. Nat Struct Biol. 2:1995;968-974.
97. Mosser G., Ravanat C., Freyssinet J.M., Brisson A. Sub-domain structure of lipid-bound Annexin-V resolved by electron image analysis. J Mol Biol. 217:1991;241-245.
98. Andree H.A., Stuart M.C., Hermens W.T., et al. Clustering of lipid-bound Annexin V may explain its anticoagulant effect. J Biol Chem. 267:1992;17907-17912.
99. Meers P., Mealy T. Calcium-dependent Annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry. 32:1993;11711-11721.
100. Van Engeland M., Ramaekers F.C.S., Schutte B., Reutelingsperger C.P.M. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 24:1996;131-139.
101. Van den Eijnde S.M., Boshart L., Reutelingsperger C.P.M., De Zeeuw C.I., Vermeij-Keers C. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Diff. 4:1997;311-316.
102. Martin S.J., Reutelingsperger C.P.M., Green D.R. Annexin V, a specific probe for apoptotic cells. Cotter T.G., Martin S.J. Techniques in apoptosis. A user's guide. 1996;107-120 Portland Press, London.
103. Castedo M., Hirsch T., Susin S.A., et al. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol. 157:1996;512-521.
104. Stuart M.C.A., Damoiseaux J.G.M.C., Frederik P.M., Arends J.W., Reutelingsperger C.P.M. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes. Eur J Cell Biol. 76:1998;77-83.
105. Bratton D.L., Fadok V.A., Richter D.A., et al. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of aminophospholipid translocase. J Biol Chem. 272:1997;26159-26165.
106. Van den Eijnde S.M., Luijsterburg A.J.M., Boshart L., et al. In situ detection of apoptosis during embryogenesis with Annexin V: from whole mount to ultrastructure. Cytometry. 29:1997;313-320.
107. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
108. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79:1996;949-956.
109. Veinot J.P., Gattinger D.A., Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol. 28:1997;485-492.
110. Bialik S., Geenen D.L., Sasson I.E., et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 100:1997;1363-1372.
111. Dumont E., Reutelingsperger C.P.M., Smits J., et al. Cardiomyocyte apoptosis induced by ischaemia and reperfusion in murine hearts: early detection with labelled Annexin-V. Lancet. 353:(Suppl. 3):1999;24.
112. Wang X., Campos B., Kaetzel M.A., Dedman J.R. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol. 180:1999;1008-1016.
113. Thornell L.E., Holmbom B., Eriksson A., et al. Enzyme and immunohistochemical assessment of myocardial damage after ischaemia and reperfusion in a closed-chest pig model. Histochemistry. 98:1992;341-353.
114. Takahashi H., Shibata Y., Fujita S., Okabe H. Immunohistochemical findings of arterial fibrinoid necrosis in major and lingual minor salivary glands of primary Sjogren's syndrome. Anal Cell Pathol. 12:1996;145-157.